AnakinraToxidermia follwing off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1751卷 / 1期

关键词：

D O I：

10.1007/s40278-019-61168-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[1] Ipilimumab/nivolumabPneumonitis follwing off-label treatment: case report
Reactions Weekly, 2019, 1775 (1) : 271 - 271
[2] PembrolizumabSick sinus syndrome follwing off-label treatment: case report
Reactions Weekly, 2018, 1715 (1) : 216 - 216
[3] RituximabHypogammaglobulinaemia follwing off-label treatment: 3 case reports
Reactions Weekly, 2019, 1746 (1) : 176 - 176
[4] RituximabCholangiohepatitis, intestinal perforation and rectal cancer follwing off-label use: case report
Reactions Weekly, 2018, 1722 (1) : 308 - 308
[5] HydroxychloroquineHepatotoxicity following off-label treatment: case report
Reactions Weekly, 2020, 1812 (1) : 148 - 148
[6] PembrolizumabNeutropenia following off-label treatment: case report
Reactions Weekly, 2021, 1851 (1) : 288 - 288
[7] RivoceranibHaemafecia following off-label treatment: case report
Reactions Weekly, 2018, 1721 (1) : 263 - 263
[8] BexaroteneTransaminitis following an off-label treatment: case report
Reactions Weekly, 2019, 1741 (1) : 59 - 59
[9] VenetoclaxNeutropenia following off-label treatment: case report
Reactions Weekly, 2021, 1849 (1) : 412 - 412
[10] FavipiravirLack of efficacy and off-label treatment: case report
Reactions Weekly, 2023, 1981 (1) : 179 - 179

← 1 2 3 4 5 →